Thoughts on Monday before AGM, page-4

1. I highly doubt opening at $1.00, it's a nice thought though. The only way it would happen is if a takeover bid was announced, then every man and his share trading dog would try get in to make a few bucks.

2. Dr Alex Hoos, also being a Senior Vice President of GSK and their range of B Cell therapies candidates brings forward the possibility of a future collaboration. It seems like they are on the same page with helping the immune system combat cancers.

Search "GSK b cell therapy Alex Hoos" and there are quite a few of articles out there.

Here is to hoping one day big pharma all start throwing their blank cheque books at us, just remember though that the more patience they have and the bigger list of successful drugs they have in their arsenal, the better the offers will be and in turn, the size of our wallets.

Only time will tell and until then we can only speculate.
All in my opinion and as always, good luck to all holders.